NCT05463913RecruitingPhase 4
Lung Nodule Detection Using Ultra-long FOV PET/CT
Ultra-long Field-Of-View Positron Emission Tomography for Characterization of Indeterminate Lung Nodules: a Pilot Study Exploring Opportunities for Clinical Research
Source: ClinicalTrials.gov · Last updated 7 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Indeterminate lung nodules (6-15mm) are frequent findings in patients undergoing chest CT scanning, but adequate follow-up imaging is currently not in place to facilitate early detection, diagnosis and decision making regarding treatment. The introduction of long Field-Of-View PET/CT scanners could make a difference in this matter due to the substantial increase in sensitivity allowing optimal image quality. Whether this new technology could provide improved detection and follow-up of indeterminate lung nodules is what we aim to explore in this study.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 22 Mar 2022
- Start date
- 13 Jul 2022
- Primary completion date
- 1 Jun 2025
- Lead sponsor
- University Medical Center Groningen
- Diseases
- Lung cancer
- NCT number
- NCT05463913
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 20
- From 13 Jul 2022 to the primary completion date, 1 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- radiation therapy of the target lung nodule(s)
Other illness
- interval of at least 2 weeks between PET scan and last date of systemic anti-cancer therapy to reduce false-negative uptake in lesions
- uncontrolled diabetes mellitus
- any medical condition potentially hampering conduction of the trial
Other
- claustrophobia
- pregnant or breastfeeding
Who the study is looking for
- able to give informed consent
- signed informed consent
- confirmed indeterminate lung nodule(s) of 6-15 mm in size on CT chest imaging
- routine 18F-FDG PET/CT performed
- scheduled for biopsy or resection of the lung nodules
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Medical Center Groningen Coordinator of this site? Confirm its status | Groningen | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.